妊娠期高血压疾病孕妇胎盘组织中HDAC8和SMAD4的表达及与妊娠结局的相关性

Expression of HDAC8 and SMAD4 in placental tissue of pregnant women with hypertensive disorder complicating pregnancy and the correlation with pregnancy outcomes

摘要

目的 探讨妊娠期高血压疾病(HDCP)孕妇胎盘组织中组蛋白去乙酰化酶8(HDAC8)、果蝇母本抗生存因子蛋白同源物4(SMAD4)的表达与疾病严重程度及妊娠结局的相关性。方法 选择2020年8月至2022年12月河北中石油中心医院收治的96例HDCP孕妇为观察对象(HDCP组),根据病情严重程度将其分为妊娠期高血压组35例,轻度子痫前期(PE)组33例,重度PE组28例;选择同期96例健康孕妇为对照组.根据妊娠结局,将HDCP孕妇分为妊娠结局良好组57例与妊娠结局不良组39例.以免疫组化法检测HDCP孕妇胎盘组织中HDAC8、SMAD4的表达水平,以实时荧光定量PCR(RT-qPCR)检测胎盘组织中HDAC8 mRNA、SMAD4 mRNA的表达水平;比较不同组别孕妇及不同妊娠结局孕妇胎盘组织中HDAC8、SMAD4的表达,以受试者工作特征(ROC)曲线分析HDAC8 mRNA、SMAD4 mRNA诊断HDCP孕妇发生不良妊娠结局的价值;采用多因素Logistic回归分析HDCP孕妇妊娠结局的影响因素。结果 HDCP组与对照组胎盘组织中HDAC8、SMAD4的阳性表达率(χ²值分别为30.561、40.776),以及HDAC8 mRNA、SMAD4 mRNA表达水平(t值分别为12.101、22.342)比较,差异均有统计学意义(P＜0.05).妊娠期高血压组、轻度PE组、重度PE组胎盘组织中HDAC8、SMAD4的阳性表达率(χ²值分别为21.055、15.903),以及HDAC8 mRNA、SMAD4 mRNA表达水平(F值分别为48.158、21.879)比较,差异均有统计学意义(P＜0.05).HDCP组与对照组早产儿、胎儿生长受限、胎儿窘迫、新生儿窒息的发生率比较差异均有统计学意义(χ²值分别为5.858、6.391、6.752、4.301,P＜0.05).妊娠结局良好组的收缩压、舒张压、24h尿蛋白及HDAC8 mRNA和SMAD4 mRNA表达水平比较,差异均有统计学意义(t值分别为2.770、5.058、3.062、7.282、6.031,P＜0.05).HDAC8 mRNA、SMAD4 mRNA及二者联合诊断HDCP孕妇发生不良妊娠结局的曲线下面积分别为0.780、0.779、0.918,二者联合诊断的曲线下面积明显高于单独诊断者(Z值分别为2.412、2.522,P＜0.05).收缩压(OR＝2.895,95％CI:1.580~5.305)、舒张压(OR＝2.342,95％CI:1.241~4.419)、SMAD4 mRNA(OR＝2.765,95％CI:1.545~4.948)均是HDCP孕妇发生不良妊娠结局的独立危险因素(P＜0.05),HDAC8 mRNA(OR＝0.764,95％CI:0.638~0.915)是HDCP孕妇发生不良妊娠结局的保护因素(P＜0.05)。结论 HDCP孕妇胎盘组织中HDAC8表达降低,SMAD4表达升高;其与孕妇病情严重程度及不良妊娠结局有关,可能参与了HDCP的发生及发展.

Abstract

Objective To investigate the correlation between the expression of histone deacetylase 8 (HDAC8) and small mother against decapentaplegic (SMAD) in placental tissue of pregnant women with hypertensive disorder complicating pregnancy (HDCP) and the severity of disease and pregnancy outcomes. Methods A total of 96 pregnant women diagnosed with HDCP at Hebei PetroChina Central Hospital from August 2020 to December 2022 were selected as the observation group (HDCP group). Based on disease severity, they were divided into three subgroups: 35 cases in the gestational hypertension group, 33 cases in the mild preeclampsia (PE) group, and 28 cases in the severe PE group. Additionally, 96 healthy pregnant women during the same period were selected as the control group. According to pregnancy outcomes, HDCP pregnant women were further divided into a good outcome group (57 cases) and a poor outcome group (39 cases). The expression levels of HDAC8 and SMAD4 in the placental tissue of HDCP pregnant women were detected using immunohistochemistry, while real-time quantitative PCR (RT-qPCR) was employed to assess the expression levels of HDAC8 mRNA and SMAD4 mRNA in placental tissue. The expression of HDAC8 and SMAD4 in different groups and different pregnancy outcome groups was compared. The diagnostic value of HDAC8 mRNA and SMAD4 mRNA for adverse pregnancy outcomes in HDCP pregnant women was analyzed using receiver operating characteristic (ROC) curves. Multivariable logistic regression was used to analyze the influencing factors of pregnancy outcomes in HDCP pregnant women. Results The positive expression rates of HDAC8 and SMAD4 in placental tissues of the HDCP group (χ²＝30.561 and 40.776, respectively, P＜0.05) and the mRNA expression levels of HDAC8 and SMAD4 (t＝12.101 and 22.342, respectively, P＜0.05) in the placental tissues of the HDCP group were significantly different from those of the control group. The positive expression rates of HDAC8 and SMAD4 in placental tissue among the gestational hypertension group, mild PE group, and severe PE group (χ²＝21.055 and 15.903, respectively, P＜0.05), as well as the expression levels of HDAC8 mRNA and SMAD4 mRNA (F＝48.158 and 21.879, respectively, P＜0.05), also demonstrated statistically significant differences. The incidence rates of preterm birth, fetal growth restriction, fetal distress, and neonatal asphyxia in the HDCP group compared to the control group were statistically significant (χ²＝5.858, 6.391, 6.752, and 4.301, respectively, P＜0.05). The systolic blood pressure, diastolic blood pressure, 24h urine protein, and expression levels of HDAC8 mRNA and SMAD4 mRNA in the good pregnancy outcome group showed statistically significant differences (t＝2.770, 5.058, 3.062, 7.282 and 6.031, respectively, P＜0.05). The area under the curve of HDAC8 mRNA, SMAD4 mRNA and the combined diagnosis of HDCP patients with adverse pregnancy outcomes were 0.780, 0.779 and 0.918, respectively, and the area under the curve of the combined diagnosis of HDCP patients was significantly higher than that of patients diagnosed alone (Z＝2.412 and 2.522, respectively, P＜0.05). Systolic blood pressure (OR＝2.895, 95％CI: 1.580-5.305), diastolic blood pressure (OR＝2.342, 95％CI: 1.241-4.419), SMAD4 mRNA (OR＝2.765, 95％CI: 1.545-4.948) was an independent risk factor for adverse pregnancy outcomes in HDCP patients (P＜0.05), while HDAC8 mRNA was a protective factor (OR＝0.764, 95％CI: 0.638-0.915, P＜0.05). Conclusion The expression of HDAC8 is decreased, and SMAD4 is increased in the placental tissue of HDCP pregnant women. These expressions are associated with the severity of the mother's condition and adverse pregnancy outcomes, and they may be involved in the occurrence and development of HDCP.

关键词

妊娠期高血压疾病 / 组蛋白去乙酰化酶8 / 果蝇母本抗生存因子蛋白同源物4 / 妊娠结局

Key words

hypertensive disorder complicating pregnancy / histone deacetylase 8 / small mother against decapentaplegic homolog 4 / pregnancy outcome

参考文献

[1] 刘佩琳, 马丽丽, 高万里. 血清PLGF、PAPP-A、β-hCG与妊娠期高血压疾病的相关性及预测不良妊娠结局价值[J]. 中国计划生育学杂志, 2022, 30(5): 1154-1158.

[2] 张长存, 张爱萍, 李玉琴. Snail高表达对子痫前期大鼠胎盘滋养细胞侵袭能力的影响及其机制[J]. 吉林大学学报(医学版), 2021, 47(4): 911-918.

[3] Maechler H, Zirlik A, McKinsey T A, et al. HDAC inhibition regulates cardiac function by increasing myofilament calcium sensitivity and decreasing diastolic tension[J]. Pharmaceutics, 2022, 14(7): 1509.

[4] Rahmani G, Moloudi M R, Amini R, et al. Effect of histone deacetylase 8 gene deletion on breast cancer cellular mechanism in vitro and in vivo study[J]. Life Sci, 2022, 311(Pt A): 121156.

[5] Kee H J, Kim G R, Lin M Q, et al. Expression of class I and class II a/b histone deacetylase is dysregulated in hypertensive animal models[J]. Korean Circ J, 2017, 47(3): 392-400.

[6] Li L, Bai Y, Du R, et al. The role of Smad4 in the regulation of insulin resistance, inflammation and cell proliferation in HTR8-Svneo cells[J]. Cell Biochem Funct, 2021, 39(1): 126-138.

[7] Qi Y, Cui S, Liu L, et al. Expression and role of miR-146a and SMAD4 in placental tissue of pregnant women with preeclampsia[J]. J Obstet Gynaecol Res, 2022, 48(8): 2151-2161.

[8] Tang X, Li G, Su F, et al. HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration a[J]. Nucleic Acids Res, 2020, 48(6): 2912-2923.

[9] 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4): 227-238.

[10] 朱志敏, 赵芳, 宋洋洋, 等. 妊娠期高血压疾病患者血清指标与妊娠结局的相关性[J]. 中国妇幼健康研究, 2023, 34(3): 29-34.

[11] Che R, Pei J, Chen H, et al. The influence of hypertensive disorders during pregnancy on the perinatal outcome of different chorionic twins[J]. J Matern Fetal Neonatal Med, 2022, 35(25): 7146-7152.

[12] 姚丽波, 朱春江, 张逢春, 等. 妊娠期高血压疾病孕妇血清胎盘生长因子、可溶性fms样酪氨酸激酶1水平变化及与妊娠结局的关系[J]. 临床和实验医学杂志, 2022, 21(18): 1960-1964.

[13] Zhang K, Zhang H, Gao S, et al. Effect and mechanism of microRNA-515-5p in proliferation and apoptosis of trophoblast cells in preeclampsia via manipulating histone deacetylase 2[J]. Mol Reprod Dev, 2023, 90(1): 59-66.

[14] Mei Z, Huang B, Zhang Y, et al. Histone deacetylase 6 negatively regulated microRNA-199a-5p induces the occurrence of preeclampsia by targeting VEGFA in vitro[J]. Biomed Pharmacother, 2019, 114(1): 108805.

[15] 白诗瑶, 赵杰禹, 孙佳敏, 等. 组蛋白去乙酰化酶8抑制剂PCI-34051抑制哮喘小鼠气道旁血管生成和VEGF/ERK信号通路活性[J]. 中国组织化学与细胞化学杂志, 2022, 31(5): 441-446.

[16] An P, Li J, Lu L, et al. Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals[J]. Eur J Pharmacol, 2019, 845(1): 16-23.

[17] Zhu L, Liu Z. Serum from patients with hypertension promotes endothelial dysfunction to induce trophoblast invasion through the miR-27b-3p/ATPase plasma membrane Ca²⁺ transporting 1 axis [J]. Mol Med Rep, 2021, 23(5): 319.

[18] Liu J, Song G, Zhao G, et al. Gene polymorphism associated with TGF-β1 and susceptibility to preeclampsia: a meta-analysis and trial sequential analysis[J]. J Obstet Gynaecol Res, 2021, 47(6): 2031-2041.

[19] 王文芳, 谭三阳, 王绪松, 等. miR-142-3p对滋养层细胞迁移、侵袭和转化生长因子-β受体1/Smad通路的影响[J]. 中国性科学, 2022, 31(4): 103-107.

[20] Zhu S, Li Z, Cui L, et al. Activin A increases human trophoblast invasion by upregulating integrin β1 through ALK4[J]. FASEB J, 2021, 35(2): e21220.

[21] Abdel Hafez F, Klausen C, Zhu H, et al. Myostatin increases human trophoblast cell invasion by upregulating N-cadherin via SMAD2/3-SMAD4 signaling[J]. Biol Reprod, 2022, 106(6): 1267-1277.

基金资助

廊坊市科技支撑计划项目(2022013125)